Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Y Ivashchenko

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Recent Patents on Cardiovascular Drug Discovery|August 25, 2011
Human embryonic and induced pluripotent stem cells in cardiovascular drug discovery: patents and patented usesChristine Y Ivashchenko
PPAR Research|February 22, 2008
PPAR-gamma in the Cardiovascular SystemSheng Zhong Duan, Christine Y Ivashchenko, Michael G Usher, et al.
Physiological Measurement|November 6, 2007
Direct monitoring pressure overload predicts cardiac hypertrophy in miceSheng Zhong Duan, Christine Y Ivashchenko, Steven E Whitesall, et al.
Circulation Research|July 30, 2005
Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in miceSheng Zhong Duan, Christine Y Ivashchenko, Mark W Russell, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 17, 2009
Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2Christine Y Ivashchenko, Benjamin T Bradley, Zhaohui Ao, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 9, 2013
Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotypeChristine Y Ivashchenko, Gordon C Pipes, Irina M Lozinskaya, et al.
The Journal of Clinical Investigation|February 17, 2007
Hypotension, lipodystrophy, and insulin resistance in generalized PPARgamma-deficient mice rescued from embryonic lethalitySheng Zhong Duan, Christine Y Ivashchenko, Steven E Whitesall, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Recent Patents on Cardiovascular Drug Discovery|August 25, 2011
Human embryonic and induced pluripotent stem cells in cardiovascular drug discovery: patents and patented usesChristine Y Ivashchenko
PPAR Research|February 22, 2008
PPAR-gamma in the Cardiovascular SystemSheng Zhong Duan, Christine Y Ivashchenko, Michael G Usher, et al.
Physiological Measurement|November 6, 2007
Direct monitoring pressure overload predicts cardiac hypertrophy in miceSheng Zhong Duan, Christine Y Ivashchenko, Steven E Whitesall, et al.
Circulation Research|July 30, 2005
Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in miceSheng Zhong Duan, Christine Y Ivashchenko, Mark W Russell, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 17, 2009
Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2Christine Y Ivashchenko, Benjamin T Bradley, Zhaohui Ao, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 9, 2013
Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotypeChristine Y Ivashchenko, Gordon C Pipes, Irina M Lozinskaya, et al.
The Journal of Clinical Investigation|February 17, 2007
Hypotension, lipodystrophy, and insulin resistance in generalized PPARgamma-deficient mice rescued from embryonic lethalitySheng Zhong Duan, Christine Y Ivashchenko, Steven E Whitesall, et al.
Pageof 1